EMA Authorised: Prezista (darunavir) — Janssen-Cilag International NV

View source ↗

Summary

EMA authorised Prezista (darunavir) for HIV infections, with the decision dated 24 July 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PREZISTA (darunavir)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Janssen-Cilag International NV. Decision date: 24/07/2024